can be directly integrated with a 96 wells microplate and it can also work in "dipstick" mode. 24
The produced crystals can be safely and directly observed inside the capillaries with optical 25 and spectroscopic techniques. The platform was validated by performing a number of 26 independent experimental runs for: (1) polymorph and hydrate screening for ortho-27 aminobenzoic acid, succinic acid and piroxicam; (2) co-crystal form screening for the p-28
Toluenesulfonamide/triphenylphosphine oxide system; (3) studying the effect of o-toluic acid 29 on ortho-aminobenzoic cooling crystallization (effect of structurally related additives). In all 30 three cases, all known solid forms were identified with a single experiment using ∼200 μL of 31 solvent and just few micrograms of solid material. The MMicroCryGen is simple to use, 32
inexpensive and it provides increased flexibility compared to traditional crystallization 33 scale crystallizers (12-14, 16, 24) . It is worth noticing that the rate of nucleation in small 87 volumes is always slower than for large crystallizers, and the formation of crystals that are 88 large enough to be analysed takes a longer time. 89
Despite the evident advantages of microfluidics technologies, current devices remain 90 expensive to produce at small scale, require bulky fluid handling equipment and present 91 solvent-compatibility issues. 92
In this work a novel multi-microfluidic platform for the generation of individual separated 93 crystals (MMicroCryGen) that allows rapid and facile screening for polymorphism and crystal 94
habit from a small sample volume is presented for the first time. In contrast to existent droplet-95 based microfluidic devices for polymorph screening (17) (18) (19) (20) the MMicroCryGen does not 96 require external pumps as sample is loaded by capillary action (similar to a conventional 97 'dipstick' test) and crystals are generated by cooling, with smoother control of the 98 supersaturation during nucleation. 99
The MMicroCryGen device shown in Figure 1a was specifically designed to perform multiple 100 cooling crystallization experiments in parallel, with the option of real-time, in-situ observation 101 of the crystals using optical or spectroscopic sensors. This platform can be used for the 102 screening of hydrates, salts and co-crystals, which are often used as expedients to improve the 103 rate of dissolution and solubility of an API, as well as to study the morphology of the crystals 104 in different solvents. 105
The main consumable of the MMicroCryGen is a set of multiplex, microfluidic strips obtained 106 via cutting a longer MicroCapillary Film (MCF). The MCF is a flat film containing an array of 107 ten parallel microcapillaries fabricated from fluorinated ethylene propylene co-polymer 108 (Teflon-FEP®) using a novel continuous melt-extrusion process (25, 26). Photos of the MCF 109 strips are shown in Figure 1b and (28), therefore they would require a pressure driven flow for sample loading; however in this 175 work the MCF strips were made hydrophilic by coating the inside of each capillary with an 176 hydrogel, poly(vinyl alcohol) (PVOH) (28). In this way the MCF strips could be filled simply 177 by capillary action ('dip stick' mode). During the coating procedure 100 mL of an aqueous 178 solution of PVOH (MW 13 000-23 000, >98 % hydrolysed from Sigma-Aldrich, Dorset, UK) 179 with concentration of 5 mg/mL was recirculated through a 6 m long MCF at a flowrate of 50 180 mL/h for 12-15 hrs using a FPLC P-500 Pharmacia Biotech (Piscataway, USA) pump andPVOH coating was crosslinked with glutaraldehyde by manually filling the MCF strip with a 183 freshly prepared solution of PVOH (5 mg/mL) containing 5 mM of glutaraldehyde (Sigma-184 Aldrich, UK) and 5 mM HCl (Sigma-Aldrich, UK). The solution was kept inside the strips for 185 2 hours at 37 °C, after which the MCF strips were manually washed and dried with air using a 186 50 mL syringe (34). 
274
The MMicroCryGen device allowed to identify all the three known forms of OABA from a 275 small amount of material, demonstrating the advantage of using this novel methodology for 276 polymorph screening. The area in the Raman spectrum that unequivocally identifies the three 277 OABA polymorphs is between 1500 and 1700 cm -1 ( Figure 5 ). Form I presents a peak at 1665 278 cm -1 and a doublet at 1600 cm -1 , form II has a strong peak at 1565 cm -1 and form III presents 279 the same peak but shifted to 1560 cm -1 . Finally, form III is characterized by a strong peak at 280 1610 cm -1 , which is not present in form I and it is weaker in form II. 281
282
The polymorphs screening experiments performed in the MMicroCryGen platform show the 283 advantage of using small volumes in the absence of mixing for the discovery of new crystal 284 structure. 285
Hydrate detection for Piroxicam 286
Piroxicam was crystallized in different mixtures of acetone and water in order to identify the 287 possible polymorphs and confirm the presence of hydrate forms. Table 2 
297
Raman spectroscopy was also used to distinguish among the polymorphs and the monohydrate 298 form of piroxicam within the MCF strips. Figure 6c shows the region between 1500 and 1700 299 cm -1 , where the three forms can be identified without interference from the FEP-Teflon®. The 300 monohydrate form is characterized by a single strong peak at 1590 cm -1 , whereas form I has a 301 high intensity peak at 1520 cm -1 and finally, form II is the only polymorph with a peak at 1540 302 cm -1 . 303
304
In the case of piroxicam, the MMicroCryGen enabled simultaneous identification of the two 305 known polymorphs and the hydrate form in a single experiment with four different solutions 306 of piroxicam in acetone and water mixtures.
Screening for co-crystals 308
A further set of experiments was carried out aiming to demonstrate the application of the 309
MMicroCryGen device to identify co-crystal structures, using p-Toluenesulfonamide (p-TSA) 310
and Triphenylphosphine oxide (TPPO) as model compounds. 311 312 The two co-crystals known for those chemicals, with molecular ratio p-TSA/TPPO 3:2 and 1:1 315 (33), were quickly and successfully identified in a single experiment in the MMicroCryGen 316 device, as confirmed by Raman spectroscopy according to data available from literature (33). 317
Experimental conditions are described in Table 3 , whereas the Raman spectra of the two co-318 crystal forms obtained are shown in Figure 7 . The Raman spectra for pure p-TSA and TPPO 319 were compared to data available in literature (33, 38), confirming the formation of two co-320 crystal forms. The characteristic regions of the Raman spectrum for the unequivocal 321 identification of the two co-crystal forms are shown in Figure 7 . Characteristic peaks for the 322 1:1 co-crystal are located at 317, 460, 507, 934 and 1151 cm -1 , whereas the 3:2 co-crystal is 323 characterized by specific peaks at 310, 915 and 1149 cm -1 (Figure 7) . 
